Filing metadata

Accession number
0001209191-22-025537
Form type
Form 4
Filer
Aclaris Therapeutics, Inc.
CIK
CIK 1557746
Filed
Apr 25, 2022
Reporting period
Apr 21, 2022
Description
Insider transaction

Explore SEC Filings Hub